These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16117473)

  • 21. Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
    Alcocer F; Novak Z; Combs BR; Lowman B; Passman MA; Mujib M; Jordan WD
    J Vasc Surg; 2014 Apr; 59(4):950-5. PubMed ID: 24491238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke: advances in therapy.
    Schellinger PD; Hacke W
    Lancet Neurol; 2005 Jan; 4(1):2. PubMed ID: 15620844
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 24. Stroke prevention.
    Lip GH; Rothwell P; Sudlow C
    Clin Evid; 2005 Dec; (14):173-97. PubMed ID: 16620404
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual Antiplatelet Therapy Does Not Increase the Risk of Bleeding After Carotid Endarterectomy: Results of a Prospective Study.
    Illuminati G; Schneider F; Pizzardi G; Masci F; Calio' FG; Ricco JB
    Ann Vasc Surg; 2017 Apr; 40():39-43. PubMed ID: 28161565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial.
    Park SM; Jeong H; Jung MH; Hong KS; Hong MK; Bang CS; Kim CY
    Contemp Clin Trials; 2017 Sep; 60():51-55. PubMed ID: 28642210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
    Steinhubl SR; Topol EJ
    J Thromb Thrombolysis; 1999 Jun; 7(3):227-31. PubMed ID: 10373712
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal antithrombotic therapy in patients receiving long-term oral anticoagulation requiring percutaneous coronary intervention: "triple therapy" or "triple threat".
    Tapp LD; Lip GYH; Lane DA
    Chest; 2011 Feb; 139(2):240-243. PubMed ID: 21285051
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clopidogrel in the treatment of atrial fibrillation: benefit from addition to aspirin. The results of ACTIVE A trial].
    Preobrazhenskiĭ DV
    Kardiologiia; 2009; 49(5):77. PubMed ID: 19463144
    [No Abstract]   [Full Text] [Related]  

  • 31. Clopidogrel plus aspirin in atrial fibrillation.
    Goldstein LB
    N Engl J Med; 2009 Sep; 361(13):1313; author reply 1314-5. PubMed ID: 19780217
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on stroke prevention.
    Kenner ME; Kelley RE
    Compr Ther; 2005; 31(2):113-8. PubMed ID: 15901940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Good old warfarin for stroke prevention in atrial fibrillation.
    Verheugt FW
    Lancet; 2006 Jun; 367(9526):1877-8. PubMed ID: 16765740
    [No Abstract]   [Full Text] [Related]  

  • 34. Clopidogrel plus aspirin in atrial fibrillation.
    Pisters R; Dinh T; Crijns HJ
    N Engl J Med; 2009 Sep; 361(13):1312; author reply 1314-5. PubMed ID: 19776416
    [No Abstract]   [Full Text] [Related]  

  • 35. [Outpatient primary stent-angioplasty in symptomatic internal carotid artery stenoses].
    Andresen R; Roth M; Brinckmann W
    Zentralbl Chir; 2003 Sep; 128(9):703-8. PubMed ID: 14533036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting.
    Wu B; Kun L; Liu X; He B
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):87-98. PubMed ID: 24048510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
    Lip GY; Karpha M
    Chest; 2006 Dec; 130(6):1823-7. PubMed ID: 17167003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel plus aspirin in atrial fibrillation.
    Richard T; Butaffuoco F; Vanhaeverbeek M
    N Engl J Med; 2009 Sep; 361(13):1313; author reply 1314-5. PubMed ID: 19780216
    [No Abstract]   [Full Text] [Related]  

  • 39. A benefit-risk assessment of agents used in the secondary prevention of stroke.
    MacWalter RS; Shirley CP
    Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticoagulation and antiaggregation in neurological patients].
    Arnold M; Nedeltchev K; Mattle HP
    Ther Umsch; 2003 Jan; 60(1):33-5. PubMed ID: 12638476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.